Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
Eur J Cancer. 2019 Oct;120:132-139. doi: 10.1016/j.ejca.2019.07.024. Epub 2019 Sep 12.
Eur J Cancer. 2019.
PMID: 31522033
Free PMC article.
Clinical Trial.
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.
Molife LR, Yan L, Vitfell-Rasmussen J, Zernhelt AM, Sullivan DM, Cassier PA, Chen E, Biondo A, Tetteh E, Siu LL, Patnaik A, Papadopoulos KP, de Bono JS, Tolcher AW, Minton S.
Molife LR, et al. Among authors: vitfell rasmussen j.
J Hematol Oncol. 2014 Jan 3;7:1. doi: 10.1186/1756-8722-7-1.
J Hematol Oncol. 2014.
PMID: 24387695
Free PMC article.
Clinical Trial.
Item in Clipboard
A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas.
Vitfell-Rasmussen J, Judson I, Safwat A, Jones RL, Rossen PB, Lind-Hansen M, Knoblauch P, Krarup-Hansen A.
Vitfell-Rasmussen J, et al.
Sarcoma. 2016;2016:2090271. doi: 10.1155/2016/2090271. Epub 2016 Jun 14.
Sarcoma. 2016.
PMID: 27403082
Free PMC article.
Item in Clipboard
A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience.
Benson C, Vitfell-Rasmussen J, Maruzzo M, Fisher C, Tunariu N, Mitchell S, Al-Muderis O, Thway K, Larkin J, Judson I.
Benson C, et al. Among authors: vitfell rasmussen j.
Anticancer Res. 2014 Jul;34(7):3663-8.
Anticancer Res. 2014.
PMID: 24982384
Item in Clipboard
89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients.
Gaykema SB, Schröder CP, Vitfell-Rasmussen J, Chua S, Oude Munnink TH, Brouwers AH, Bongaerts AH, Akimov M, Fernandez-Ibarra C, Lub-de Hooge MN, de Vries EG, Swanton C, Banerji U.
Gaykema SB, et al. Among authors: vitfell rasmussen j.
Clin Cancer Res. 2014 Aug 1;20(15):3945-54. doi: 10.1158/1078-0432.CCR-14-0491.
Clin Cancer Res. 2014.
PMID: 25085789
Item in Clipboard
Real-life incidence of cardiotoxicity and associated risk factors in sarcoma patients receiving doxorubicin.
Vitfell-Rasmussen J, Krarup-Hansen A, Vaage-Nilsen M, Kümler T, Zerahn B.
Vitfell-Rasmussen J, et al.
Acta Oncol. 2022 Jul;61(7):801-808. doi: 10.1080/0284186X.2022.2082884. Epub 2022 Jun 11.
Acta Oncol. 2022.
PMID: 35695121
Item in Clipboard
Tumor reduction and symptom relief after electrochemotherapy in a patient with aggressive fibromatosis - a case report.
Vitfell-Rasmussen J, Sandvik RM, Dahlstrøm K, Al-Farra G, Krarup-Hansen A, Gehl J.
Vitfell-Rasmussen J, et al.
Acta Oncol. 2018 Mar;57(3):431-434. doi: 10.1080/0284186X.2017.1363406. Epub 2017 Aug 16.
Acta Oncol. 2018.
PMID: 28812409
No abstract available.
Item in Clipboard
Cite
Cite